Preparation of monoclonal antibodies reactive to a hallucinogenic drug, psilocin

Journal of Health Science

Volumn 50, Issue 6, 2004, Pages 600-604

  Yamaguchi, Mitsune ^a   Saito, Toshiaki ^a   Horiguchi, Yoshie ^a   Ogawa, Keita ^a   Tsuchiya, Yukihiro ^a   Hishinuma, Kayoko ^a   Chikuma, Toshiyuki ^a   Makino, Yukiko ^b   Hojo, Hiroshi ^a  

^a SHOWA PHARMACEUTICAL UNIVERSITY   (Japan)

^b Japan Ministry of Health Labour and Welfare   (Japan)

Author keywords

Enzyme immunoassay; Magic mushroom; Monoclonal antibody; Psilocin

Indexed keywords

CARRIER PROTEIN; DIAGNOSTIC AGENT; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INDOLE DERIVATIVE; KEYHOLE LIMPET HEMOCYANIN; MONOCLONAL ANTIBODY; N [4 [3 (2 DIMETHYLAMINOETHYL)INDOL 4 YL OXY]BUTYL]SUCCINAMIC ACID; N,N DIMETHYLTRYPTAMINE; PSILOCIN; PSILOCIN MONOCLONAL ANTIBODY; PSILOCYBINE; TRYPTAMINE; TRYPTOPHAN; UNCLASSIFIED DRUG;

ACTIVE IMMUNIZATION; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CROSS REACTION; DIAGNOSTIC VALUE; DRUG STRUCTURE; ENZYME IMMUNOASSAY; FEMALE; HYBRIDOMA CELL CULTURE; MOLECULAR CLONING; MOUSE; MUSHROOM; MYELOMA CELL; NONHUMAN; SPLEEN CELL; SYNTHESIS;

ANIMALIA; BASIDIOMYCOTA; PSILOCYBE CUBENSIS;

EID: 24744438928     PISSN: 13449702     EISSN: None     Source Type: Journal    
DOI: 10.1248/jhs.50.600     Document Type: Article

References (13)

1. Hatfield, G. M., Valdes, L. J. and Smith, A. H. (1978) The occurrence of psilocybin in Gymnopilus species. Lloydia, 41, 140-144.
2. Benkert, O. and Hippius, H. (1992) Psychiatrische Pharmakotherapie, Springer Verlag, Berlin.
3. McCall, R. B. and Aghajanian, G. K. (1980) Hallucinogens potentiate responses to serotonin and norepinephrine in the facial motor nucleus. Life Sci., 26, 1149-1156.
4. Beug, M. W. and Bigwood, J. (1981) Quantitative analysis of psilocybin and psilocin in psilocybe baecystis (Singer and Smith) by high-performance liquid chromatography and thin-layer chromatography. J. Chromatogr., 207, 379-385.
5. Pedersen-Bjergaard, S., Sannes, E., Rasmussen, K. E. and Tonnesen, F. (1997) Determination of psilocybin in Psilocybe semilanceata by capillary zone electrophoresis. J. Chromatogr. B, 694, 375-381.
6. Fales, H. M. and Pisano, J. J. (1962) Gas chromatography of biologically important amines. Anal. Biochem., 3, 337-342.
7. Wurst, M., Semerdzieva, M. and Vokoun, J. (1984) Analysis of psychotropic compounds in fungi of the genus psilocybe by reversed-phase high-performance liquid chromatography. J. Chromatogr. A, 286, 229-235.
8. Wurst, M., Kysilka, R. and Koza, T. (1989) High-performance liquid chromatographic determination of some psychotropic indole derivatives. J. Chromatogr. A, 464, 434-437.
9. Porstmann, T. and Kiessig, S. T. (1992) Enzyme immunoassay techniques. J. Immunol. Methods, 150, 5-21.
10. Shirota, O., Hakamata, W. and Goda, Y. (2003) Concise large-scale synthesis of psilocin and psilocybin, principal hallucinogenic constituents of "magic mushroom." J. Nat. Prod., 66, 885-887.
11. Kobayashi, N., Taniguchi, K. and Urasawa, S. (1990) Identification of operationally overlapping and independent cross-reactive neutralization regions on human rotavirus VP4. J. Gen. Virol., 71, 2615-2623.
12. Albers, C., Lehr, M., Beike, J., Kohler, H. and Brinkmann, B. (2002) Synthesis of a psilocin hapten and a protein-hapten conjugate. J. Pharm. Pharmacol., 54, 1265-1270.
13. Musshoff, F., Madea, B. and Beike, J. (2000) Hallucinogenic mushrooms on the German market - simple instructions for examination and identification. For. Sci. Int., 113, 389-395.